Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06894771
What this trial is testing

MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 5
Testing effectiveness (Phase 2)Study completedNCT00044564
What this trial is testing

Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Bayer 54
Not applicableStudy completedNCT02184416
What this trial is testing

Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting

Who this might be right for
Metastatic Renal Cell Carcinoma (mRCC)
Pfizer 554
Testing effectiveness (Phase 2)Study completedNCT01136733
What this trial is testing

E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment

Who this might be right for
Metastatic Renal Cell Carcinoma
Eisai Inc. 173
Testing effectiveness (Phase 2)Active Not RecruitingNCT04322955
What this trial is testing

CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition

Who this might be right for
Kidney CancerRenal Cell Carcinoma
Mark Stein 38
Not applicableUnknownNCT04891055
What this trial is testing

Prospective Translational Study Investigating Predictors of Outcome in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab (I-Rene Trial)

Who this might be right for
Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 90
Early research (Phase 1)Study completedNCT04834778
What this trial is testing

HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)

Who this might be right for
Renal Cell CarcinomaGastric CancerMetastatic Breast Cancer+2 more
HiberCell, Inc. 23
Large-scale testing (Phase 3)Study completedNCT01668784
What this trial is testing

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

Who this might be right for
Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
Bristol-Myers Squibb 821
Not applicableStudy completedNCT05432947
What this trial is testing

68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 42
Early research (Phase 1)Ended earlyNCT01115803
What this trial is testing

LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors

Who this might be right for
Metastases, NeoplasmCarcinoma, Non-small Cell LungRenal Cell Carcinoma+1 more
Eli Lilly and Company 29
Testing effectiveness (Phase 2)Looking for participantsNCT05363280
What this trial is testing

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

Who this might be right for
Small Cell Lung CancerRenal Cell Carcinoma (RCC)Non-Small Cell Lung
Advenchen Pharmaceuticals, LLC. 80
Large-scale testing (Phase 3)Looking for participantsNCT06364631
What this trial is testing

CARE1 Pragmatic Clinical Trial

Who this might be right for
Metastatic Kidney CancerMetastatic Kidney Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris 1,250
Large-scale testing (Phase 3)Ended earlyNCT03729245
What this trial is testing

Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Nektar Therapeutics 623
Not applicableStudy completedNCT04005183
What this trial is testing

Renal Cell Carcinoma Microenvironment Discovery Project

Who this might be right for
Renal Cell Carcinoma
University Health Network, Toronto 146
Testing effectiveness (Phase 2)WithdrawnNCT00574483
What this trial is testing

Treatment of Advanced Renal Cell Carcinoma With Quinacrine

Who this might be right for
Renal Cell Carcinoma
Cleveland BioLabs
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07816770
What this trial is testing

MANTIS-RCC: Toripalimab-Axitinib Induction in TLS-Positive Advanced Non-Clear Cell and Renal Medullary Carcinomas

Who this might be right for
Metastatic Non-Clear Cell Renal Cell CarcinomaMetastatic Renal Medullary Carcinomas
Fudan University 30
Early research (Phase 1)Temporarily pausedNCT07181720
What this trial is testing

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Lung CancerAnaplastic Thyroid Carcinomas+3 more
Chongqing Precision Biotech Co., Ltd 90
Testing effectiveness (Phase 2)Looking for participantsNCT06642220
What this trial is testing

Ablative Radioembolization of Renal Cell Carcinoma Trial

Who this might be right for
Renal Cell Carcinoma (RCC)Radioembolization
Derek W. Cool 16
Early research (Phase 1)Active Not RecruitingNCT02298959
What this trial is testing

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Colorectal CarcinomaMetastatic Malignant Solid Neoplasm+12 more
National Cancer Institute (NCI) 59
Not applicableUnknownNCT02001493
What this trial is testing

Metabolomic Profiling in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Cambridge University Hospitals NHS Foundation Trust 60
Next Page